- Home
- BMRA vs AIMD Comparison
BMRA vs AIMD Comparison
Compare BMRA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- AIMD
- Stock Information
- Founded
- BMRA 1971
- AIMD 1984
- Country
- BMRA United States
- AIMD United States
- Employees
- BMRA N/A
- AIMD N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- AIMD Health Care
- Exchange
- BMRA Nasdaq
- AIMD Nasdaq
- Market Cap
- BMRA 11.2M
- AIMD 9.9M
- IPO Year
- BMRA N/A
- AIMD N/A
- Fundamental
- Price
- BMRA $3.54
- AIMD $0.55
- Analyst Decision
- BMRA
- AIMD
- Analyst Count
- BMRA 0
- AIMD 0
- Target Price
- BMRA N/A
- AIMD N/A
- AVG Volume (30 Days)
- BMRA 43.6K
- AIMD 197.4K
- Earning Date
- BMRA 04-14-2025
- AIMD 05-12-2025
- Dividend Yield
- BMRA N/A
- AIMD N/A
- EPS Growth
- BMRA N/A
- AIMD N/A
- EPS
- BMRA N/A
- AIMD N/A
- Revenue
- BMRA $5,678,000.00
- AIMD $20,729.00
- Revenue This Year
- BMRA N/A
- AIMD N/A
- Revenue Next Year
- BMRA N/A
- AIMD N/A
- P/E Ratio
- BMRA N/A
- AIMD N/A
- Revenue Growth
- BMRA 5.01
- AIMD N/A
- 52 Week Low
- BMRA $1.92
- AIMD $0.40
- 52 Week High
- BMRA $10.16
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- BMRA 39.79
- AIMD 52.35
- Support Level
- BMRA $3.18
- AIMD $0.52
- Resistance Level
- BMRA $3.93
- AIMD $0.59
- Average True Range (ATR)
- BMRA 0.47
- AIMD 0.05
- MACD
- BMRA -0.05
- AIMD 0.00
- Stochastic Oscillator
- BMRA 20.00
- AIMD 50.70
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.